Three Concord College sixth form students have gained valuable insights into future cancer treatments, as part of an exciting research placement at the University of Wolverhampton.
The students joined Professor Wang, Dr Vinodh Kannappans and the cancer research team from the Faculty of Science and Engineering at the University. The team are currently investigating the treatment of aggressive, resistant cancers with high mortality rates, such as pancreatic cancer, brain tumours and lung cancer, with the aim of improving patient outcomes.
Concord College is an academic independent international school in England for day and boarding students which welcomes students from all over the world and the local area.
Concord’s Course Liaison Coordinator, Zoe Torsney, said: “It is a very exciting time for the research group as they embark on their quest to develop their nano-particle technology. Their method of delivering drugs directly to the tumour site has incredible implications for the efficacy of future cancer treatments.”
The experience is part of Concord’s placements initiative for prospective medical students and is designed to help pupils make more informed decisions regarding university choices and what they’d like to do in the future.
Doraleen said: “We have learned things far beyond our syllabus and we were able to expand on our existing knowledge. We learnt the processes of culturing cells, testing medications and applying different doses using a variety of methods and equipment. It was a valuable opportunity to be able to witness such a notable medical project, and it has prepared us for what we can anticipate at a higher level of learning. We are extremely grateful.”
Zoe said: “The placement has been a source of real inspiration for our students, beyond what they can access in the classroom. Seeing ground-breaking and potentially life-changing research in action has given them the impetus to really strive towards their own personal goals, for future studies. Our aim is to stimulate students and inform their wider reading and research interests, enabling them to produce more competitive applications for top medical schools.”
The University of Wolverhampton is playing a central role in a £600k project to develop an anti-cancer therapy as part of an international research and development collaboration.
The Jiangsu-UK Industrial Challenge Programme, co-funded by Innovate UK and Jiangsu Science and Technology Department in China, includes £90k of laboratory-based research to be carried out by the Cancer Research Group in the University’s Faculty of Science and Engineering.
Led by the Professor of Experimental Cancer Therapeutics, Weiguang Wang, the Cancer Research Group is developing a treatment based on Disulfiram, an existing drug used to treat alcoholism which is showing promising results in pre-clinical testing as a new anti-cancer therapy.